PLA2R Immunohistochemistry Staining in Membranous Glomerulopathy: A Challenging Stain to Interpret But a Potentially Useful Diagnostic Tool

Circulating autoantibodies to phospholipase A2 receptor (PLA2R-Ab) are detected in >70% of patients with primary membranous glomerulonephritis (MGN). Detection of PLA2R antigen in renal tissue, with immunohistochemistry (PLA2R IHC), strongly correlates with serum PLA2R-Ab, although it is more sensitive. As PLA2R IHC in literature has no univocal interpretation, we suggest reliable criteria for a standard approach for the assessment of immunostaining for differential diagnosis between primary and secondary MGN. We analyzed PLA2R IHC expression in 40 biopsies of patients with MGN and serum PLA2R-Ab titer at the time of biopsy. We carefully evaluated, at high magnification, the immunostaining pattern and distribution, regardless of intensity, in capillary loops, mesangium, and podocytes of all glomeruli.We defined, adopting this approach, positive stain when a granular pattern, coarse and/or fine, diffuse or focal, and global or segmental were observed. Negative stain was defined by mesangial staining, when there was a dirty pattern, or a peripheral staining of capillary loops with a smoky linear pattern. Podocytes showed homogenous cytoplasmatic stain both in positive and negative cases and in external negative controls. We found PLA2R IHC and serum PLA2R-Ab positivity in early-middle stage MGN compared with advanced stage more frequently. Correct stratification of patients with MGN needs PLA2R-Ab detection in serum and renal tissue. PLA2R IHC test, although a challenging stain, can be an easy diagnostic tool but requires reliable interpretation keys for a standard approach to the assessment of immunostaining.

[1]  Chong Zhang,et al.  Clinicopathological features in membranous nephropathy with cancer: A retrospective single-center study and literature review , 2019, The International journal of biological markers.

[2]  Baoli Liu,et al.  Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role , 2019, Front. Immunol..

[3]  Yuliang Zhao,et al.  Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis , 2019, International Urology and Nephrology.

[4]  R. Stahl,et al.  Diagnostic role of renal biopsy in PLA2R1-antibody-positive patients with nephrotic syndrome , 2019, Modern Pathology.

[5]  F. Pieruzzi,et al.  Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain , 2018, Journal of Nephrology.

[6]  Kyung-Hee Kim,et al.  The Usefulness of Phospholipase A2 Receptor and IgG4 Detection in Differentiation Primary Membranous Nephropathy From Secondary Membranous Nephropathy in Renal Biopsy , 2017, Applied immunohistochemistry & molecular morphology : AIMM.

[7]  M. Uppin,et al.  Immunohistochemical Analysis of Anti-phospholipase A2 Receptor Antibody on Renal Biopsies: A Single Tertiary Care Center Study , 2017, Indian journal of nephrology.

[8]  S. Varughese,et al.  Immunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations , 2017, Nephron Extra.

[9]  W. Luo,et al.  Detection and clinical significance of glomerular M‐type phospholipase A2 receptor in patients with idiopathic membranous nephropathy , 2016, Internal medicine journal.

[10]  Hong Cheng,et al.  Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy , 2016, PloS one.

[11]  B. Haraldsson,et al.  Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy , 2015, Clinical kidney journal.

[12]  M. Haas,et al.  Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods. , 2015, Clinical nephrology.

[13]  Xiaoye Zhu,et al.  Renal Phospholipase A2 Receptor in Hepatitis B Virus-Associated Membranous Nephropathy , 2015, American Journal of Nephrology.

[14]  T. Itoh,et al.  Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype , 2015, Virchows Archiv.

[15]  H. Debiec,et al.  Anti-Phospholipase A2 Receptor Antibodies and the Pathogenesis of Membranous Nephropathy , 2014, Nephron Clinical Practice.

[16]  Nora Hornig,et al.  Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1. , 2014, Autoimmunity reviews.

[17]  N. Valtierra,et al.  Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[18]  V. Tesar,et al.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  U. Panzer,et al.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. , 2012, Kidney international.

[20]  克治 桑門 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[21]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.